// App-Quantinova.ai

5002 : A randomized study of finite abiraterone acetate (AA) plus leuprolide (LHRHa) versus LHRHa in biochemically recurrent non metastatic hormone naive prostate cancer (M0HNPC).

Researchers

Presenter

  • Eleni Efstathiou

Principal Investigators

  • Xuemei Wang

  • Amado J. Zurita

  • Shi-Ming Tu

  • Ana Aparicio

  • Jennifer Wang

  • Paul Gettys Corn

  • Sumit Kumar Subudhi

  • John C. Araujo

  • Lawanda K Reece

  • Lisa Pruitt

  • Michael L Vanalstine

  • Christopher Logothetis

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • CB-7598

  • Leuprolide acetate

  • Prednisone

Outcome

  • N/A

Study Design

  • Randomized

  • Cross Over

Phase

  • NA

Study Id's

  • NCT01786265

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved